KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $627000.0.

  • Evolent Health's Deferred Taxes rose 16691.57% to $627000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year increase of 9401.44%. This contributed to the annual value of -$3.0 million for FY2024, which is 9679.48% up from last year.
  • Latest data reveals that Evolent Health reported Deferred Taxes of $627000.0 as of Q3 2025, which was up 16691.57% from -$865000.0 recorded in Q2 2025.
  • Evolent Health's Deferred Taxes' 5-year high stood at $777000.0 during Q4 2022, with a 5-year trough of -$68.7 million in Q1 2023.
  • Its 5-year average for Deferred Taxes is -$7.5 million, with a median of -$238000.0 in 2021.
  • Data for Evolent Health's Deferred Taxes shows a peak YoY increase of 42647.06% (in 2022) and a maximum YoY decrease of 23418500.0% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Evolent Health's Deferred Taxes stood at -$238000.0 in 2021, then skyrocketed by 426.47% to $777000.0 in 2022, then plummeted by 2037.97% to -$15.1 million in 2023, then skyrocketed by 92.87% to -$1.1 million in 2024, then surged by 158.43% to $627000.0 in 2025.
  • Its Deferred Taxes was $627000.0 in Q3 2025, compared to -$865000.0 in Q2 2025 and $295000.0 in Q1 2025.